Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT).

McHugh, DJ; Funt, S; Silber, D; Knezevic, A; Patil, S; O'Donnell, D; Tsai, S; Reuter, VE; Sheinfeld, J; Carver, BS; Motzer, RJ; Bajorin, DF; Bosl, GJ; Feldman, DR

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (6):